These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 21624664
21. Influence of previous tuberculin skin test on serial IFN-γ release assays. Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, Ajassa C, Vullo V, Mastroianni CM. Tuberculosis (Edinb); 2011 Jul; 91(4):322-6. PubMed ID: 21664872 [Abstract] [Full Text] [Related]
22. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study. Tiwari S, Kumar A, Kapoor SK. Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709 [Abstract] [Full Text] [Related]
23. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Respir Res; 2006 May 17; 7(1):77. PubMed ID: 16707012 [Abstract] [Full Text] [Related]
24. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response. Sauzullo I, Mengoni F, Ermocida A, Massetti AP, D'Agostino C, Russo G, Salotti A, Falciano M, Vullo V, Mastroianni CM. New Microbiol; 2014 Apr 17; 37(2):153-61. PubMed ID: 24858642 [Abstract] [Full Text] [Related]
25. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clin Infect Dis; 2006 Dec 15; 43(12):1540-6. PubMed ID: 17109285 [Abstract] [Full Text] [Related]
32. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(1) tuberculosis outbreak in a Cram School]. Fukazawa K. Kekkaku; 2007 Jan 15; 82(1):53-9. PubMed ID: 17310782 [Abstract] [Full Text] [Related]
33. Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa. Moyo S, Isaacs F, Gelderbloem S, Verver S, Hawkridge AJ, Hatherill M, Tameris M, Geldenhuys H, Workman L, Pai M, Hussey G, Hanekom WA, Mahomed H. Int J Tuberc Lung Dis; 2011 Sep 15; 15(9):1176-81, i. PubMed ID: 21943841 [Abstract] [Full Text] [Related]
34. In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. Sauzullo I, Mengoni F, Lichtner M, Massetti AP, Rossi R, Iannetta M, Marocco R, Del Borgo C, Soscia F, Vullo V, Mastroianni CM. PLoS One; 2009 Sep 15; 4(4):e5187. PubMed ID: 19365543 [Abstract] [Full Text] [Related]
35. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA. Clin Infect Dis; 2007 Oct 01; 45(7):837-45. PubMed ID: 17806047 [Abstract] [Full Text] [Related]
36. Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment. Bartalesi F, Goletti D, Spinicci M, Cavallo A, Attala L, Mencarini J, Fiori G, Li Gobbi F, Mantella A, Benucci M, Prignano F, Pimpinelli N, Matucci Cerinic M, Girardi E, Bartoloni A. J Infect; 2013 Apr 01; 66(4):346-56. PubMed ID: 23103667 [Abstract] [Full Text] [Related]
39. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. Ra SW, Lyu J, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. Int J Tuberc Lung Dis; 2011 May 01; 15(5):635-40. PubMed ID: 21756514 [Abstract] [Full Text] [Related]
40. No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test. Hoogewerf M, Boland GJ, Hoepelman AI, Boer WH, Mudrikova T. J Nephrol; 2011 May 01; 24(5):625-30. PubMed ID: 21298615 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]